Allogeneic and autologous stem cell transplantation for hepatosplenic T-cell lymphoma: a retrospective study of the EBMT Lymphoma Working Party
Alina Tănase(Institutul Clinic Fundeni), Norbert Schmitz(University Hospital Münster), Luca Castagna(Humanitas University), Didier Blaise(Institut Paoli-Calmettes), Nöel Milpied(Hôpital Cardiologique du Haut-Lévêque), Hervé Finel, Antonı́n Vı́tek(Institute of Haematology and Blood Transfusion), Anna Sureda(Institut d'Investigació Biomédica de Bellvitge), Elisabeth Vandenberghe(Trinity College Dublin), Harald Stein(Franklin University), Peter Dreger(Heidelberg University), Kirsty Thomson(University College Hospital), Ariane Boumendil(Inserm), Gülsan Sucak(Gazi University)
Cited by 73
Related Papers
KTE-X19 CAR T-Cell Therapy in Relapsed or Refractory Mantle-Cell Lymphoma
|New England Journal of Medicine|2020|1.9k
Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
|New England Journal of Medicine|2013|1.6k
Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma
|New England Journal of Medicine|2021|1.6k
Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60)
|The Lancet Oncology|2008|1.1k
A Biologic Definition of Burkitt's Lymphoma from Transcriptional and Genomic Profiling
|New England Journal of Medicine|2006|1k